On June 6, 2025, Marker Therapeutics, Inc. held its Annual Meeting where stockholders approved all proposals, including the election of four directors with 67.43% share participation. The nominees received significant votes: David Eansor (4,095,249), Steven Elms (4,094,745), Katharine Knobil (4,079,812), and Juan Vera (4,143,496).